694 related articles for article (PubMed ID: 7554521)
21. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
Saeed B; Ossman MI; Sheriff S
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporine experience in nephrotic syndrome.
Phadke K; Ballal S; Maiya V
Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
[TBL] [Abstract][Full Text] [Related]
23. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
[TBL] [Abstract][Full Text] [Related]
25. Glomerular growth under cyclosporine treatment in childhood nephrotic syndrome.
Jeong HJ; Kim JH; Kim PK; Choi IJ
Clin Nephrol; 2001 Apr; 55(4):289-96. PubMed ID: 11334314
[TBL] [Abstract][Full Text] [Related]
26. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
[TBL] [Abstract][Full Text] [Related]
27. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
29. [Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types].
Xia ZK; Liu GL; Gao YF; Fu J; Fu YF; Zhang LF; Fan ZM
Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):813-6. PubMed ID: 14728885
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
[TBL] [Abstract][Full Text] [Related]
31. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.
Hamasaki Y; Yoshikawa N; Nakazato H; Sasaki S; Iijima K; Nakanishi K; Matsuyama T; Ishikura K; Ito S; Kaneko T; Honda M;
Pediatr Nephrol; 2013 May; 28(5):765-71. PubMed ID: 23314441
[TBL] [Abstract][Full Text] [Related]
32. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[TBL] [Abstract][Full Text] [Related]
33. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
[TBL] [Abstract][Full Text] [Related]
34. The rarity of minimal change disease in Nigerian patients with the nephrotic syndrome.
Kadiri S; Osobamiro O; Ogunniyi J
Afr J Med Med Sci; 1993 Dec; 22(4):29-34. PubMed ID: 7839926
[TBL] [Abstract][Full Text] [Related]
35. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
Sabry A; El-Husseini A; El-Dahshan K; Sobh M
Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic management of adult idiopathic nephrotic syndrome.
Alaniz C; Brosius FC; Palmieri J
Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
[TBL] [Abstract][Full Text] [Related]
37. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
38. Steroid resistant nephrotic syndrome: role of histopathology.
Gulati S; Sengupta D; Sharma RK; Sharma A; Gupta RK; Singh U; Gupta A
Indian Pediatr; 2006 Jan; 43(1):55-60. PubMed ID: 16465008
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
Goumenos DS; Tsagalis G; El Nahas AM; Shortland JR; Davlouros P; Vlachojannis JG; Brown CB
Nephron Clin Pract; 2006; 104(2):c75-82. PubMed ID: 16785738
[TBL] [Abstract][Full Text] [Related]
40. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
Gulati S; Kher V
Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
